← Leaderboards
Anna Palatnik
Medical College Of Wisconsin
$4,552,656
Attributed
$5,180,842
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2022–25$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$9,521,622 · 5
By mechanism
R01$4,532,842 · 3
U54$4,340,780 · 1
R34$648,000 · 1
Top collaborators
- Julia B Dickson-Gomez3 shared
- Jessica M Olson3 shared
- Joni Strom Williams3 shared
- Margaret Bublitz1 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Leonard E. Egede$19,076,991
- Joni Strom Williams$2,603,589
- Jessica M Olson$1,868,461
- Joan Pleuss$0
Others in their field
Other Rising Stars on “Pregnancy”
- Christine W Hockett · Avera Mckennan$8,908,366
- Hong-Ngoc B. Nguyen · University Of Minnesota$6,812,121
- Sunni L. Mumford · University Of Pennsylvania$6,439,627
- Burton Rochelson · Feinstein Institute For Medical Research$5,891,324
- Michele Caggana · Nysdoh/Health Research, Inc.$4,856,614
- Lidia Minguez Alarcon · Brigham And Women'S Hospital$4,645,231
Research focus
PregnancyBirthExposure ToRandomizedRandomized, Controlled TrialsPreventProviderRacial DisparityEnsurePostpartum PeriodDesignPre-EclampsiaMaternal-Fetal MedicineResponseCardiovascular SystemGuidelinesVariantAffectClinical PracticeParticipantInnovationBlood PressureLevel Of EvidencePharmacotherapy
Grant awards (13)
Addressing Key Social Contributors to Disparities in MatErNal MorbiDity in Southeastern Wisconsin - ASCEND WI Center$1,537,127
U54 · FY2025 · HD · contact PI
MINDBP - Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy$1,256,373
R01 · FY2025 · AT · contact PI
Reducing the risk of chronic hypertension and improving vascular function following preeclampsia$624,684
R01 · FY2025 · HD · contact PI
Gestational Diabetes and Pharmacotherapy (GAP) â A Randomized Controlled Trial Investigating Timing of Pharmacotherapy Initiation for Patients with Gestational Diabetes$504,901
R01 · FY2025 · HD · contact PI
Intensive postpartum antihypertensive treatment to improve women's cardiovascular health$216,000
R34 · FY2025 · HL · contact PI
Addressing Key Social-Structural Risk Factors for Racial Disparities in Maternal Morbidity in Southeastern Wisconsin (ASCEND WI)$1,542,406
U54 · FY2024 · HD · contact PI
Reducing the risk of chronic hypertension and improving vascular function following preeclampsia$632,110
R01 · FY2024 · HD · contact PI
Gestational Diabetes and Pharmacotherapy (GAP) â A Randomized Controlled Trial Investigating Timing of Pharmacotherapy Initiation for Patients with Gestational Diabetes$493,477
R01 · FY2024 · HD · contact PI
Intensive postpartum antihypertensive treatment to improve women's cardiovascular health$216,000
R34 · FY2024 · HL · contact PI
Addressing Key Social-Structural Risk Factors for Racial Disparities in Maternal Morbidity in Southeastern Wisconsin (ASCEND WI)$1,261,247
U54 · FY2023 · HD · contact PI
Gestational Diabetes and Pharmacotherapy (GAP) â A Randomized Controlled Trial Investigating Timing of Pharmacotherapy Initiation for Patients with Gestational Diabetes$501,908
R01 · FY2023 · HD · contact PI
Intensive postpartum antihypertensive treatment to improve women's cardiovascular health$216,000
R34 · FY2023 · HL · contact PI
Gestational Diabetes and Pharmacotherapy (GAP) â A Randomized Controlled Trial Investigating Timing of Pharmacotherapy Initiation for Patients with Gestational Diabetes$519,389
R01 · FY2022 · HD · contact PI